PROshot: Locoregional therapy for metastatic breast cancer, abiraterone in very high-risk prostate cancer, neoadjuvant chemoradiation for resectable pancreatic cancer, radiation for oligometastatic EGFR-mutated lung cancer, and PORT for N2 lung cancer Editorial


Authors: Dulaney, C.; Dover, L.
Title: PROshot: Locoregional therapy for metastatic breast cancer, abiraterone in very high-risk prostate cancer, neoadjuvant chemoradiation for resectable pancreatic cancer, radiation for oligometastatic EGFR-mutated lung cancer, and PORT for N2 lung cancer
Journal Title: Practical Radiation Oncology
Volume: 12
Issue: 3
ISSN: 1879-8519
Publisher: Elsevier Inc.  
Date Published: 2022-05-01
Start Page: 179
End Page: 184
Language: English
DOI: 10.1016/j.prro.2022.02.007
PROVIDER: scopus
PUBMED: 35512988
DOI/URL:
Notes: Editorial -- Export Date: 1 June 2022 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Laura Lynne Dover
    14 Dover
Related MSK Work